Log in

TapImmune News Headlines (NASDAQ:MRKR)

$4.16
-0.19 (-4.37 %)
(As of 10/20/2019 02:58 PM ET)
Today's Range
$4.10
Now: $4.16
$4.40
50-Day Range
$4.19
MA: $5.22
$6.19
52-Week Range
$3.97
Now: $4.16
$9.90
Volume230,047 shs
Average Volume195,596 shs
Market Capitalization$189.99 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12

Headlines

TapImmune (NASDAQ MRKR) News Headlines

Source:
DateHeadline
TapImmune Inc. (NASDAQ:MRKR) Receives Average Recommendation of "Buy" from AnalystsTapImmune Inc. (NASDAQ:MRKR) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - October 15 at 1:37 AM
We Think Marker Therapeutics (NASDAQ:MRKR) Can Afford To Drive Business GrowthWe Think Marker Therapeutics (NASDAQ:MRKR) Can Afford To Drive Business Growth
finance.yahoo.com - October 8 at 12:41 PM
Zacks: Analysts Expect TapImmune Inc. (NASDAQ:MRKR) Will Announce Earnings of -$0.13 Per ShareZacks: Analysts Expect TapImmune Inc. (NASDAQ:MRKR) Will Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - October 5 at 7:38 AM
Marker Therapeutics Reports Second Quarter 2019 Operating and Financial ResultsMarker Therapeutics Reports Second Quarter 2019 Operating and Financial Results
finance.yahoo.com - August 8 at 8:56 PM
Do Insiders Own Shares In Marker Therapeutics, Inc. (NASDAQ:MRKR)?Do Insiders Own Shares In Marker Therapeutics, Inc. (NASDAQ:MRKR)?
finance.yahoo.com - August 8 at 3:53 PM
Marker Therapeutics Appoints Steve Elms to its Board of DirectorsMarker Therapeutics Appoints Steve Elms to its Board of Directors
finance.yahoo.com - August 6 at 8:54 PM
Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic AdenocarcinomaMarker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma
finance.yahoo.com - July 17 at 12:03 PM
Hedge Funds Have Never Been This Bullish On Marker Therapeutics, Inc. (MRKR)Hedge Funds Have Never Been This Bullish On Marker Therapeutics, Inc. (MRKR)
finance.yahoo.com - June 29 at 11:03 AM
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic AdenocarcinomaMarker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
finance.yahoo.com - June 20 at 8:59 AM
Will Marker Therapeutics Surge Higher?Will Marker Therapeutics Surge Higher?
finance.yahoo.com - June 13 at 9:50 AM
Marker Therapeutics to Present at Two Upcoming Investor ConferencesMarker Therapeutics to Present at Two Upcoming Investor Conferences
finance.yahoo.com - May 21 at 9:02 AM
Should Marker Therapeutics (NASDAQ:MRKR) Be Disappointed With Their 89% Profit?Should Marker Therapeutics (NASDAQ:MRKR) Be Disappointed With Their 89% Profit?
finance.yahoo.com - May 10 at 3:42 PM
Marker Therapeutics Reports First Quarter 2019 Operating and Financial ResultsMarker Therapeutics Reports First Quarter 2019 Operating and Financial Results
finance.yahoo.com - May 10 at 12:14 PM
MARKER THERAPEUTICS, INC. (MRKR) Reports Q1 Loss, Lags Revenue EstimatesMARKER THERAPEUTICS, INC. (MRKR) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 10 at 12:14 PM
Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care ConferenceMarker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
finance.yahoo.com - May 8 at 12:13 PM
Here's Why Marker Therapeutics Fell as Much as 11.5% TodayHere's Why Marker Therapeutics Fell as Much as 11.5% Today
finance.yahoo.com - April 17 at 3:41 PM
The Daily Biotech Pulse: Safety Board Clears Eisais Alzheimers Study, Positive Trial Results For Galapagos-GileadThe Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead
finance.yahoo.com - March 29 at 11:13 AM
Marker Therapeutics Provides Business and Clinical UpdateMarker Therapeutics Provides Business and Clinical Update
finance.yahoo.com - March 29 at 11:13 AM
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic SteelZacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
finance.yahoo.com - March 29 at 11:13 AM
Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28thMarker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th
finance.yahoo.com - March 18 at 10:44 AM
Marker Therapeutics: Phenomenal Data In Lymphoma And Other Indications, Yet Little Recognition From The StreetMarker Therapeutics: Phenomenal Data In Lymphoma And Other Indications, Yet Little Recognition From The Street
seekingalpha.com - March 15 at 3:35 PM
Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
finance.yahoo.com - February 25 at 11:43 AM
Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement AwardMarker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award
finance.yahoo.com - February 22 at 9:31 AM
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical DevelopmentMarker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
finance.yahoo.com - February 7 at 9:11 AM
Marker Therapeutics to Present at the 2019 BIO CEO & Investor ConferenceMarker Therapeutics to Present at the 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 6 at 9:32 AM
Does Market Volatility Impact Marker Therapeutics, Inc.’s (NASDAQ:MRKR) Share Price?Does Market Volatility Impact Marker Therapeutics, Inc.’s (NASDAQ:MRKR) Share Price?
finance.yahoo.com - February 4 at 3:29 PM
Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019
finance.yahoo.com - January 17 at 9:18 AM
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
finance.yahoo.com - January 16 at 8:51 AM
Marker Therapeutics up 12% premarket after pipeline updateMarker Therapeutics up 12% premarket after pipeline update
seekingalpha.com - January 4 at 9:40 AM
Marker Therapeutics Provides Updates of its Lead Clinical ProgramsMarker Therapeutics Provides Updates of its Lead Clinical Programs
finance.yahoo.com - January 4 at 9:40 AM
Marker Therapeutics Inc.Marker Therapeutics Inc.
www.barrons.com - December 31 at 3:20 PM
These 4 Healthcare Stocks May Test December HighsThese 4 Healthcare Stocks May Test December Highs
finance.yahoo.com - December 31 at 3:20 PM
Marker Therapeutics Exits ASH An Optimist. Should That Be Enough For You?Marker Therapeutics Exits ASH An Optimist. Should That Be Enough For You?
seekingalpha.com - December 12 at 7:28 AM
Nomura/Instinet Starts Marker Therapeutics (MRKR) at BuyNomura/Instinet Starts Marker Therapeutics (MRKR) at Buy
www.streetinsider.com - November 29 at 3:18 PM
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual MeetingThe Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
finance.yahoo.com - November 28 at 6:39 AM
Marker Therapeutics (MRKR) Appoints Anthony H. Kim as CFOMarker Therapeutics (MRKR) Appoints Anthony H. Kim as CFO
www.streetinsider.com - November 27 at 3:18 PM
Marker Therapeutics to Present at Three Upcoming Healthcare ConferencesMarker Therapeutics to Present at Three Upcoming Healthcare Conferences
finance.yahoo.com - November 8 at 3:18 PM
Marker Therapeutics, Inc. Announces New Executive AppointmentsMarker Therapeutics, Inc. Announces New Executive Appointments
finance.yahoo.com - October 24 at 5:18 AM
Marker to Present at Two Upcoming Cellular Therapy ConferencesMarker to Present at Two Upcoming Cellular Therapy Conferences
finance.yahoo.com - October 22 at 4:40 PM
True Nature Holding Inc. Strengthens Board of Advisors With Appointment of Michael J. LoiaconoTrue Nature Holding Inc. Strengthens Board of Advisors With Appointment of Michael J. Loiacono
finance.yahoo.com - October 22 at 4:40 PM
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel